Pluri Inc.'s PluriCDMO™ Nominated for CDMO of the Year Award at Advanced Therapies Awards 2025
Pluri's CDMO division has been nominated for the CDMO of the Year Award shortly after its launch.Quiver AI SummaryPluri Inc., a biotechnology company based in Haifa, Israel, announced that its PluriCDMO™...
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...
Pluri CEO Issues Shareholder Update
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem...
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries
As of July 26, 2022, Pluri’s stock will trade under the symbol PLURThe new name reflects the Company’s strategy to leverage its innovative 3D cell-based...